Your session is about to expire
← Back to Search
Behavioral Intervention
Dialectical Behavior Therapy for Suicide Risk in Psychosis
N/A
Recruiting
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
At least 18 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up four months
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to help people with psychotic disorders manage their emotions better, as they are at high risk of suicide. By improving emotional control, the treatment hopes to reduce suicidal thoughts and behaviors in this group.
Who is the study for?
This trial is for adults with a psychosis spectrum disorder confirmed by an interview, who are already receiving outpatient mental health services. They must be able to read at a 6th-grade level and have a heightened risk of suicide as indicated by specific questionnaire scores. People with intellectual disabilities, traumatic brain injury, or deafness cannot participate.
What is being tested?
The study tests Dialectical Behavior Therapy Skills Training aimed at managing emotional turmoil in people with psychotic disorders to reduce their suicide risk. It includes advanced data collection methods like Ecological Momentary Assessment for real-time tracking of emotions and behaviors.
What are the potential side effects?
Since the intervention involves therapy rather than medication, typical medical side effects are not expected. Participants may experience emotional discomfort when discussing difficult topics during therapy sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ four months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~four months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Emotion Dysregulation
Feeling suicidal (finding)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Dialectical Behavior Therapy - Skill TrainingExperimental Treatment1 Intervention
Group II: Treatment As UsualActive Control1 Intervention
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for psychosis include antipsychotic medications, cognitive-behavioral therapy (CBT), and electroconvulsive therapy (ECT). Antipsychotics primarily work by blocking dopamine receptors, which helps to reduce the symptoms of psychosis such as hallucinations and delusions.
CBT focuses on changing negative thought patterns and behaviors, which can improve emotional regulation and reduce distress. ECT, though its exact mechanism is not fully understood, is believed to induce changes in brain chemistry that can rapidly alleviate severe symptoms.
These treatments are crucial for psychosis patients as they not only target the core symptoms but also help in managing emotional dysregulation, which is a significant factor in reducing suicide risk.
Relapse prevention in ambulant mental health care tailored to patients with schizophrenia or bipolar disorder.Pharmacologic treatment of schizophrenia.
Relapse prevention in ambulant mental health care tailored to patients with schizophrenia or bipolar disorder.Pharmacologic treatment of schizophrenia.
Find a Location
Who is running the clinical trial?
University of Maryland, BaltimoreLead Sponsor
716 Previous Clinical Trials
381,046 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I have been actively participating in outpatient mental health services.You are at risk of committing suicide, as indicated by a score of 8 or more on a questionnaire. The score cutoff may be lowered if it's hard to find enough people to participate, but it won't be raised above 8.
Research Study Groups:
This trial has the following groups:- Group 1: Dialectical Behavior Therapy - Skill Training
- Group 2: Treatment As Usual
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.